课题基金 / 基金详情

Elucidation of the link between the control of cell-cell adhesion by regulations of cell polarity and cell proliferation and differentitation

Elucidation of the link between the control of cell-cell adhesion by regulations of cell polarity and cell proliferation and differentitation
阐明细胞极性调节对细胞间粘附的控制与细胞增殖和分化之间的联系
批准号:
18570142
负责人:
IZAWA Ichiro
金额:
$2.63万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

IZAWA Ichiro的其他基金

相似基金

相关文献

中文摘要
翻译
LAP(富亮氨酸重复序列(LRR)和PSD-95/DLG/ZO-1(PDZ))家族蛋白包括Scribble、Let-413、Erbin、Densin-180和Lano,参与细胞极性的调节。据报道,LAP蛋白的LRR结构域调节其基侧膜的定位,并对其功能至关重要。为了进一步剖析Erbin的质膜定位机制,我们将Erbin的各种突变体导入培养细胞中,并观察了Erbin在细胞内的定位。当在氨基(N)末端缺失1-32个氨基酸残基的LRR区突变体在细胞中过表达时,突变体不定位于质膜,而定位于细胞质。我们发现Erbin N-末端的半胱氨酸14和16在体内是棕榈酰化的。半胱氨酸14和/或半胱氨酸16转变为丝氨酸的突变体没有在质膜上定位,这表明Erbin的棕榈酰化是其质膜定位所必需的。Erbin过表达的1-196个氨基酸片段没有LRR的后半部分,是棕榈酰化的,但不定位在质膜上。这些结果表明,Erbin的质膜定位既需要棕榈酰化,也需要LRR。
英文摘要
LAP(leucine-rich repeats(LRR) and PSD-95/Dlg/ZO-1(PDZ)) family proteins, including Scribble, LET-413, ERBIN, Densin-180, and Lano, are involved in the regulation of cell polarity. The LRR domains of LAP proteins were reported to mediate their basolateral membrane localization and to be essential for their function. To further dissect the mechanism of the plasma membrane localization of ERBIN, we introduced various mutants of ERBIN into cultured cells and observed the intracellular localization. When an LRR domain mutant lacking amino acid residues 1-32 at the amino(N) terminal region was overexpressed in cells, the mutant did not localize at the plasma membrane, but localized in the cytoplasm. We found that cysteines 14 and 16 at the N-terminal region of ERBIN are in vivo palmitoylated. Overexpression of the mutants in which cysteine 14 and/or cysteine 16 were changed to serines did not localize at the plasma membrane, indicating that the palmitoylation of ERBIN is necessary for its plasma membrane localization. The overexpressed 1-196 amino acids fragment of ERBIN, which lacked the latter half of LRR, was palmitoylated but did not localize at the plasma membrane. These results suggest that both palmitoylation and LRR are required for the plasma membrane localization of ERBIN.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
実験医学 第24巻第13号「形と運動を司る細胞のダイナミクス」第1章 6.中間径フィラメントの構築制御とシグナルクロストーク
实验医学第24卷第13期“控制形状和运动的细胞动力学”第1章6.中间丝结构和信号串扰的控制
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [T., Mimuro, et. al., 井澤一郎]
通讯作者: 井澤一郎
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Izawa. I., Nishizawa, M., Inagaki, M.]
通讯作者: M.
細胞極性制御分子ERBINの形質膜移行メカニズムの解析
细胞极性控制分子ERBIN质膜转位机制分析
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [M., Sugawa, et. al., 井澤一郎]
通讯作者: 井澤一郎
DOI: 10.1111/j.1365-2443.2006.00961.x
发表时间: 2006-05
期刊: Genes to Cells
影响因子: 2.1
作者: [Takashi Oguri;Akihito Inoko;H. Shima;I. Izawa;N. Arimura;Tomoya Yamaguchi;N. Inagaki;K. Kaibuchi;K. Kikuchi;M. Inagaki]
通讯作者: Takashi Oguri;Akihito Inoko;H. Shima;I. Izawa;N. Arimura;Tomoya Yamaguchi;N. Inagaki;K. Kaibuchi;K. Kikuchi;M. Inagaki
共 8 条
    Development of peptide inhibitors targeting ADAM10 to eradicate brain tumor-initiating cells
    • 批准号:
      26670650
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      IZAWA Ichiro
    • 依托单位:
    Elucidation of biological functions of CD133, a marker for brain tumor-initiating cells, and its application
    • 批准号:
      24659659
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      IZAWA Ichiro
    • 依托单位:
    Analysis of abnormal cell polarity in brain tumor cells
    • 批准号:
      21591887
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      IZAWA Ichiro
    • 依托单位:
    Dissection of roles of Densin-180, a cell polarity molecule, in synapses
    • 批准号:
      16500257
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2004
    • 负责人:
      IZAWA Ichiro
    • 依托单位:
    国内基金
    海外基金
    中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
    • 批准号:
      81673007
    • 项目类别:
      面上项目
    • 资助金额:
      54.0万元
    • 批准年份:
      2016
    • 负责人:
      金时
    • 依托单位: